Dingli David, Michor Franziska
Program for Evolutionary Dynamics, Harvard University, One Brattle Square, Suite 6, Cambridge, Massachusetts 02138, USA.
Stem Cells. 2006 Dec;24(12):2603-10. doi: 10.1634/stemcells.2006-0136. Epub 2006 Aug 24.
Despite significant improvements in cancer therapy, tumor recurrence is frequent and can be due to a variety of mechanisms, including the evolution of resistance and tumor progression. Cancer stem cells have been postulated to maintain tumor growth similar to normal stem cells maintaining tissue homeostasis. Recently, the existence of these malignant stem cells has been proven for hematological as well as some solid tumors. Tumor stem cells are not targeted by standard therapy and might be responsible for treatment failure and tumor recurrence in many patients. We designed a simple mathematical model to demonstrate the importance of eliminating tumor stem cells. We explored different therapeutic scenarios to illustrate the properties required from novel therapeutic agents for successful tumor treatment. We show that successful therapy must eradicate tumor stem cells.
尽管癌症治疗取得了显著进展,但肿瘤复发仍然很常见,可能是由于多种机制,包括耐药性的演变和肿瘤进展。有人推测癌症干细胞维持肿瘤生长的方式类似于正常干细胞维持组织稳态。最近,已经证实这些恶性干细胞存在于血液系统肿瘤以及一些实体瘤中。肿瘤干细胞不受标准疗法的靶向作用,可能是许多患者治疗失败和肿瘤复发的原因。我们设计了一个简单的数学模型来证明消除肿瘤干细胞的重要性。我们探索了不同的治疗方案,以说明成功治疗肿瘤所需的新型治疗药物的特性。我们表明,成功的治疗必须根除肿瘤干细胞。